NCT03150979

Brief Summary

Previous studies failed to determine the real effects of the provision of a walking cane after a stroke, mainly due to biases related to their methodological designs. In addition, there is no information on the carry-over effects of a cane to social participation. This study will test the hypothesis that the provision of a cane is effective in improving walking speed, step length, cadence, walking capacity, walking confidence, and participation of individuals with chronic stroke. For this prospective, single-blinded, randomized clinical trial, people after stroke will be randomly allocated into either experimental or control groups. The experimental group will receive a single-point cane, with ergonomic handgrip, which will be individually adjusted to the participant's height. A physiotherapist will provide instructions on how to walk with the cane and the participants will practice for about 15 minutes or until they feel comfortable with the device. Then, they will take the cane home and will be instructed to use it all the time during locomotion. Weekly, they will receive a phone call, to ensure that they are using the cane and to clarify any doubts. A home visit may be conducted, if necessary. The control group will be instructed to perform stretching of the lower limb muscles daily and keep their daily activities, without the use of a cane. To ensure the level of attention similar to that of the participants in the experimental group, the individuals in the control group will also receive weekly phone calls. At baseline (Week 0), post intervention (Week 4), and one month after the cessation (Week 8) of the interventions, researchers blinded to group allocations will collect all outcome measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 12, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

2.1 years

First QC Date

May 9, 2017

Last Update Submit

March 24, 2020

Conditions

Keywords

StrokeAssistive devicesGaitRehabilitationClinical trial

Outcome Measures

Primary Outcomes (1)

  • Walking speed

    Changes in walking speed, in m/s, assessed by the 10-m Walk Test.

    Baseline (week 0), after intervention (week 4) and one-month follow-up (week 8)

Secondary Outcomes (5)

  • Walking step length

    Baseline (week 0), after intervention (week 4) and one-month follow-up (week 8)

  • Walking cadence

    Baseline (week 0), after intervention (week 4) and one-month follow-up (week 8)

  • Walking capacity

    Baseline (week 0), after intervention (week 4) and one-month follow-up (week 8)

  • Walking confidence

    Baseline (week 0), after intervention (week 4) and one-month follow-up (week 8)

  • Social Participation

    Baseline (week 0), after intervention (week 4) and one-month follow-up (week 8)

Study Arms (2)

Provision of a cane

EXPERIMENTAL

The experimental group will receive a single-point cane, with ergonomic handgrip, which will be individually adjusted to the participant's height. A physiotherapist will provide instructions on how to walk with the cane and the participants will practice for about 15 minutes or until they feel comfortable with the device. Then, they will take the cane home and will be instructed to use it all the time during locomotion. Weekly, they will receive a phone call, to ensure that they are using the cane and to clarify any doubts. A home visit may be conducted, if necessary.

Other: Provision of a cane

Control

OTHER

The control group will be instructed to to perform stretching of the lower limb muscles daily and keep their daily activities, without the use of a cane. They will also receive weekly phone calls, to ensure similar level of attention to that of the the participants in the experimental group.

Other: Control

Interventions

The participants will receive a single-point cane and will be instructed to use it all the time during locomotion. Weekly, they will receive a phone call, to ensure that they are using the cane and to clarify any doubts. A home visit may be conducted, if necessary.

Provision of a cane
ControlOTHER

The control group will be instructed to to perform stretching of the lower limb muscles daily and keep their daily activities, without the use of a cane. They will also receive weekly phone calls, to ensure similar level of attention to that of the the participants in the experimental group.

Control

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • People with stroke will be eligible if they are \>6 months after the onset of their first stroke,
  • \>20 years of age,
  • Able to walk at least 14 meters, independently, walk with a speed ≤0.8 m/s or less, and
  • Are naïve to use any assistive device.

You may not qualify if:

  • Individuals with cognitive impairments, double hemiparesis, or any other non-stroke related conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Physical Therapy, Universidade Federal de Minas Gerais

Belo Horizonte, Minas Gerais, 31270-901, Brazil

Location

NeuroGroup Laboratory

Belo Horizonte, Minas Gerais, 31270-901, Brazil

Location

MeSH Terms

Conditions

Stroke

Interventions

Canes

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Orthopedic EquipmentSurgical EquipmentEquipment and Supplies

Study Officials

  • Luci F Teixeira-Salmela, Ph.D.

    Federal University of Minas Gerais

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, single-blinded, randomized, clinical trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Titular Professor

Study Record Dates

First Submitted

May 9, 2017

First Posted

May 12, 2017

Study Start

August 1, 2017

Primary Completion

August 31, 2019

Study Completion

December 31, 2019

Last Updated

March 25, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations